Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$46.1B
120M shares
52-week range
$163.11 – $397.99
99% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
CS
Borrow rate
0.40%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $56.94B | $64.93B | $77.19B | $83.65B | $92.92B | $106.44B | $117.81B | $129.66B |
| Cost of revenue | $45.75B | $53.74B | $61.50B | $69.20B | $75.69B | $88.39B | $100.66B | $110.81B |
| Gross profit | $11.19B | $11.19B | $15.69B | $14.45B | $17.23B | $18.05B | $17.15B | $18.85B |
| Gross margin | 19.7% | 17.2% | 20.3% | 17.3% | 18.5% | 17.0% | 14.6% | 14.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $2.07B | $3.47B | $4.67B | $3.42B | $3.56B | $3.32B | $1.63B | $1.45B |
| EBITDA | $2.83B | $4.29B | $5.57B | $4.46B | $4.81B | $4.73B | $3.25B | $2.91B |
| Net income | $1.68B | $2.71B | $3.37B | $2.93B | $2.81B | $2.49B | $1.21B | $1.19B |
| Net margin | 3.0% | 4.2% | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| EPS (diluted) | 12.16 | 20.10 | 25.31 | 22.67 | 22.08 | 20.00 | 9.98 | 9.84 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $162.1B | $8.85 | $8.27–$9.17 | 15 |
| 2027 | $169.7B | $15.84 | $13.51–$19.05 | 15 |
| 2028 | $179.4B | $26.34 | $20.04–$32.21 | 7 |
| 2029 | $188.2B | $32.39 | $31.02–$34.70 | 2 |
Forward consensus · source: Financial Modeling Prep
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
www.humana.comNo one on the platform currently holds HUM.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 9,953 | $2.5M |
| Bridgewater Associatesas of 2025-09-30 | 6,603 | $1.7M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-26 | $0.8850 | 2026-07-31 |
| 2026-03-27 | $0.8850 | 2026-04-24 |
| 2025-12-26 | $0.8850 | 2026-01-30 |
| 2025-09-26 | $0.8850 | 2025-10-31 |
| 2025-06-27 | $0.8850 | 2025-07-25 |
| 2025-03-28 | $0.8850 | 2025-04-25 |
| 2024-12-31 | $0.8850 | 2025-01-31 |
| 2024-09-30 | $0.8850 | 2024-10-25 |
| 2024-06-28 | $0.8850 | 2024-07-26 |
| 2024-03-27 | $0.8850 | 2024-04-26 |
No one on the platform has traded HUM yet.
| $28.9B |
| — |
| HLNHaleon plc | $9.34 | +0.05% | $41.2B | — |
| INSMInsmed Incorporated | $107.20 | +2.35% | $23.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-28 |
| $0.8850 |
| 2024-01-26 |
| 2023-09-28 | $0.8850 | 2023-10-27 |
$HUM this is a wierd one in comparison to peers. Especially considering they cant afford to pay commissions to their agents rn. Kinda think we see sub 300 on earnings.
View on StockTwits ↗$HUM Damn ......this one hurt bulls, but congratulations to all the ones that held through hell a few months ago. Talk about timing....it looks like I took my mental break from the markets at the wrong time, lol Altho I walked away break-even or with a slight profit....it looks like I left 185k on the table!!!!! 🤬
View on StockTwits ↗$HUM this stock will be at $1000 a share soon .. Mark my words. Use to be at 600 . Easy money 💰
View on StockTwits ↗$CLOV According to Grok, there is a deal in the works with Humana $HUM
View on StockTwits ↗$HUM Current Stock Price: $383.57 Contracts to trade: $382.5 HUM Jun 26 2026 Call Entry: $0.10 Exit: $0.19 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$CLOV $HUM just hit a 52 wk high, following $UNH and $CLOV
View on StockTwits ↗@jacksparo we are waiting for $HUM for shorts to pay their price as well
View on StockTwits ↗$CI $CNC $CVS $HUM $UNH Healthcare stocks own 2026 besides the crazy chip stocks.
View on StockTwits ↗$ASTH here’s math. 350mm 27 ebitda 14x ($INNV trades for this valuation; max health acquired by $HUM a few months ago for this valuation) 4.9bn -500mm net debt $4.4bn /55mm shares $80/sh target price This isn’t a stretch and this isn’t a meme stock. This is a real cash flowing biz with years of 15-20% growth runway.
View on StockTwits ↗@cynicaloptimist @BustaCapital @Jblack500 @MaverikIT @IsabellaDC @WAJeff $MOH $UNH $HUM $OSCR $CNC alerting again to managed care stock sector. Day 1 of MOH breakout. This breakout took more than 4 attempts and some time to develop which makes me respect the move more. Led the way in the sector today in terms of vol vs avg. Now just give me a little backtest to make one more buy.
View on StockTwits ↗$MOH $HUM since i flagged hum breakout in may it's up 75 dollars. Day 1 of breakout in MOH, will possibly look to add on backtest of it even though i already added on break 205
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 27.9× earnings vs its 24.5× historical median P/E.
Fair value ≈ $346.73 · price $395.49 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.